Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Autoimmune Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Merck
Lexicon Pharmaceuticals
Pfizer
AstraZeneca
Novartis
Antares Pharma
Eisai
Boehringer Ingelheim
Can-Fite BioPharma
KaloBios Pharmaceuticals
GSK
Johnson & Johnson
Amgen
Vertex Pharmaceuticals
Acorda Therapeutics
Takeda Pharmaceuticals
Sanofi
Eli Lilly
By Type:
Psoriasis
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Inflammatory Bowel Disease (IBD)
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
By Application:
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Autoimmune Drugs Market Overview 2018-2029
-
1.1 China Autoimmune Drugs Industry Development Overview
-
1.2 China Autoimmune Drugs Industry Development History
-
1.3 China Autoimmune Drugs Industry Market Size (2018-2029)
-
1.4 China Autoimmune Drugs Market Analysis by Type from Production Side
-
1.4.1 China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Psoriasis (2018-2029)
-
1.4.2 China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Ankylosing Spondylitis (AS) (2018-2029)
-
1.4.3 China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Systemic Lupus Erythematosus (SLE) (2018-2029)
-
1.4.4 China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Inflammatory Bowel Disease (IBD) (2018-2029)
-
1.4.5 China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Rheumatoid Arthritis (RA) (2018-2029)
-
1.4.6 China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Multiple Sclerosis (MS) (2018-2029)
-
1.5 China Autoimmune Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Autoimmune Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Autoimmune Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Autoimmune Drugs Market Analysis by Region
-
1.6.1 North China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Autoimmune Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Autoimmune Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Autoimmune Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Autoimmune Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Autoimmune Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Autoimmune Drugs Industry Development
Chapter 3 Autoimmune DrugsIndustry Chain Analysis
-
3.1 Autoimmune Drugs Industry Chain
-
3.2 Autoimmune Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Autoimmune Drugs Market
-
3.3 Autoimmune Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Autoimmune Drugs Market
Chapter 4 China Autoimmune Drugs Market, by Type
-
4.1 China Autoimmune Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Autoimmune Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Autoimmune Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Autoimmune Drugs Production Volume and Growth Rate of Psoriasis
-
4.5.2 China Autoimmune Drugs Production Volume and Growth Rate of Ankylosing Spondylitis (AS)
-
4.5.3 China Autoimmune Drugs Production Volume and Growth Rate of Systemic Lupus Erythematosus (SLE)
-
4.5.4 China Autoimmune Drugs Production Volume and Growth Rate of Inflammatory Bowel Disease (IBD)
-
4.5.5 China Autoimmune Drugs Production Volume and Growth Rate of Rheumatoid Arthritis (RA)
-
4.5.6 China Autoimmune Drugs Production Volume and Growth Rate of Multiple Sclerosis (MS)
Chapter 5 China Autoimmune Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Autoimmune Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Autoimmune Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Autoimmune Drugs Market Size and Growth Rate of Clinic
-
5.5.2 China Autoimmune Drugs Market Size and Growth Rate of Hospital
Chapter 6 China Autoimmune Drugs Market, by Region
-
6.1 China Autoimmune Drugs Production Volume and Production Value, by Region
-
6.2 China Autoimmune Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Autoimmune Drugs Market Analysis
-
7.1 North China Autoimmune Drugs Market, by Type
-
7.2 North China Autoimmune Drugs Market, by Application
Chapter 8 Central China Autoimmune Drugs Market Analysis
-
8.1 Central China Autoimmune Drugs Market, by Type
-
8.2 Central China Autoimmune Drugs Market, by Application
Chapter 9 South China Autoimmune Drugs Market Analysis
-
9.1 South China Autoimmune Drugs Market, by Type
-
9.2 South China Autoimmune Drugs Market, by Application
Chapter 10 East China Autoimmune Drugs Market Analysis
-
10.1 East China Autoimmune Drugs Market, by Type
-
10.2 East China Autoimmune Drugs Market, by Application
Chapter 11 Northeast China Autoimmune Drugs Market Analysis
-
11.1 Northeast China Autoimmune Drugs Market, by Type
-
11.2 Northeast China Autoimmune Drugs Market, by Application
Chapter 12 Southwest China Autoimmune Drugs Market Analysis
-
12.1 Southwest China Autoimmune Drugs Market, by Type
-
12.2 Southwest China Autoimmune Drugs Market, by Application
Chapter 13 Northwest China Autoimmune Drugs Market Analysis
-
13.1 Northwest China Autoimmune Drugs Market, by Type
-
13.2 Northwest China Autoimmune Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Merck
-
14.1.1 Merck Company Profile
-
14.1.2 Merck Autoimmune Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Lexicon Pharmaceuticals
-
14.2.1 Lexicon Pharmaceuticals Company Profile
-
14.2.2 Lexicon Pharmaceuticals Autoimmune Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Pfizer
-
14.3.1 Pfizer Company Profile
-
14.3.2 Pfizer Autoimmune Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Profile
-
14.4.2 AstraZeneca Autoimmune Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile
-
14.5.2 Novartis Autoimmune Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Antares Pharma
-
14.6.1 Antares Pharma Company Profile
-
14.6.2 Antares Pharma Autoimmune Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Eisai
-
14.7.1 Eisai Company Profile
-
14.7.2 Eisai Autoimmune Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Profile
-
14.8.2 Boehringer Ingelheim Autoimmune Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Can-Fite BioPharma
-
14.9.1 Can-Fite BioPharma Company Profile
-
14.9.2 Can-Fite BioPharma Autoimmune Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 KaloBios Pharmaceuticals
-
14.10.1 KaloBios Pharmaceuticals Company Profile
-
14.10.2 KaloBios Pharmaceuticals Autoimmune Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 GSK
-
14.11.1 GSK Company Profile
-
14.11.2 GSK Autoimmune Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Johnson & Johnson
-
14.12.1 Johnson & Johnson Company Profile
-
14.12.2 Johnson & Johnson Autoimmune Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Amgen
-
14.13.1 Amgen Company Profile
-
14.13.2 Amgen Autoimmune Drugs Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Vertex Pharmaceuticals
-
14.14.1 Vertex Pharmaceuticals Company Profile
-
14.14.2 Vertex Pharmaceuticals Autoimmune Drugs Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Acorda Therapeutics
-
14.15.1 Acorda Therapeutics Company Profile
-
14.15.2 Acorda Therapeutics Autoimmune Drugs Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Takeda Pharmaceuticals
-
14.16.1 Takeda Pharmaceuticals Company Profile
-
14.16.2 Takeda Pharmaceuticals Autoimmune Drugs Market Performance
-
14.16.3 Product&Service Introduction
-
14.17 Sanofi
-
14.17.1 Sanofi Company Profile
-
14.17.2 Sanofi Autoimmune Drugs Market Performance
-
14.17.3 Product&Service Introduction
-
14.18 Eli Lilly
-
14.18.1 Eli Lilly Company Profile
-
14.18.2 Eli Lilly Autoimmune Drugs Market Performance
-
14.18.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Autoimmune Drugs Industry Research Conclusions
-
15.2 Autoimmune Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Autoimmune Drugs Industry Market Size (2018-2029)
-
Figure China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Psoriasis (2018-2029)
-
Figure China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Ankylosing Spondylitis (AS) (2018-2029)
-
Figure China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Systemic Lupus Erythematosus (SLE) (2018-2029)
-
Figure China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Inflammatory Bowel Disease (IBD) (2018-2029)
-
Figure China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Rheumatoid Arthritis (RA) (2018-2029)
-
Figure China Autoimmune Drugs Production Volume, Production Value and Growth Rate of Multiple Sclerosis (MS) (2018-2029)
-
Figure China Autoimmune Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Autoimmune Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Autoimmune Drugs Market Size and Growth Rate from 2018-2029
-
Figure Autoimmune Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Autoimmune Drugs Market Share by Type in 2018
-
Figure China Autoimmune Drugs Market Share by Type in 2023
-
Figure China Autoimmune Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Autoimmune Drugs Production Volume and Growth Rate of Psoriasis (2018-2023)
-
Figure China Autoimmune Drugs Production Volume and Growth Rate of Ankylosing Spondylitis (AS) (2018-2023)
-
Figure China Autoimmune Drugs Production Volume and Growth Rate of Systemic Lupus Erythematosus (SLE) (2018-2023)
-
Figure China Autoimmune Drugs Production Volume and Growth Rate of Inflammatory Bowel Disease (IBD) (2018-2023)
-
Figure China Autoimmune Drugs Production Volume and Growth Rate of Rheumatoid Arthritis (RA) (2018-2023)
-
Figure China Autoimmune Drugs Production Volume and Growth Rate of Multiple Sclerosis (MS) (2018-2023)
-
Figure China Autoimmune Drugs Market Share by Application in 2018
-
Figure China Autoimmune Drugs Market Share by Application in 2023
-
Figure China Autoimmune Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Autoimmune Drugs Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Autoimmune Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Autoimmune Drugs Production Volume by Region (2018-2023)
-
Table China Autoimmune Drugs Production Volume Share by Region (2018-2023)
-
Figure China Autoimmune Drugs Production Volume Share by Region (2018-2023)
-
Table China Autoimmune Drugs Production Value by Region (2018-2023)
-
Table China Autoimmune Drugs Production Value Share by Region (2018-2023)
-
Figure China Autoimmune Drugs Production Value Share by Region (2018-2023)
-
Table China Autoimmune Drugs Sales Volume by Region (2018-2023)
-
Table China Autoimmune Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Autoimmune Drugs Sales Volume Share by Region (2018-2023)
-
Table China Autoimmune Drugs Sales Value by Region (2018-2023)
-
Table China Autoimmune Drugs Sales Value Share by Region (2018-2023)
-
Figure China Autoimmune Drugs Sales Value Share by Region (2018-2023)
-
Table North China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table North China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table North China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table North China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table Central China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table Central China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table South China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table South China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table South China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table East China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table East China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table East China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Autoimmune Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Autoimmune Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Autoimmune Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Autoimmune Drugs Sales Volume Share by Application (2018-2023)
-
Table Merck Company Profile
-
Table Merck Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Lexicon Pharmaceuticals Company Profile
-
Table Lexicon Pharmaceuticals Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Antares Pharma Company Profile
-
Table Antares Pharma Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Eisai Company Profile
-
Table Eisai Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Can-Fite BioPharma Company Profile
-
Table Can-Fite BioPharma Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table KaloBios Pharmaceuticals Company Profile
-
Table KaloBios Pharmaceuticals Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table GSK Company Profile
-
Table GSK Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Johnson & Johnson Company Profile
-
Table Johnson & Johnson Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Vertex Pharmaceuticals Company Profile
-
Table Vertex Pharmaceuticals Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Acorda Therapeutics Company Profile
-
Table Acorda Therapeutics Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceuticals Company Profile
-
Table Takeda Pharmaceuticals Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Autoimmune Drugs Revenue, Price and Gross (2018-2023)
-
